Portfolio company
CUTISS
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops bioengineered, personalised skin grafts for patients requiring surgery for severe burns or reconstructive procedures.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
AddGraft Therapeutics
This company develops genetically engineered liquid skin grafts for patients with rare skin diseases and metabolic disorders.
VERITACELL
This company produces surgical kits for point-of-care skin cell isolation and regeneration to help surgeons and hospitals treat patient wounds and scarring.
Cellbricks
Cellbricks develops 3D-bioprinted human tissue implants and vascularised therapeutics for patients with complex wounds, soft tissue defects and organ damage.
Aurealis Pharma
This company develops cell and gene therapies for patients suffering from chronic wounds, cancer and inflammatory diseases.
EsaDres
The company develops personalised wound dressings using electrospinning technology for patients in hospitals to improve healing and reduce infection risks.
Kerecis
This company develops fish skin tissue regeneration products for medical professionals to treat patients with chronic wounds, burns and surgical complications.
PLCOSKIN
This company manufactures 3D-printed biodegradable hybrid mesh scaffolds for reconstructive surgeons and hospitals to support natural soft tissue regeneration and healing.
Skinuvita
This company develops teledermatology software and hardware for home phototherapy to treat patients with chronic skin conditions under medical supervision.